Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
RGC Resources
RGCO
$223M
| $1.06M | ﹤0.01% |
37,198
+9,698
| +35% | +$281K |
|
2602
ProShares Ultra QQQ
QLD
$12.7B
| $1.06M | ﹤0.01% |
69,600
+41,600
| +149% | +$563K |
|
2603
Twin Disc
TWIN
$329M
| $1.06M | ﹤0.01% |
96,193
+42,000
| +78% | +$439K |
|
2604
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.22B
| $1.06M | ﹤0.01% |
39,944
+13,841
| +53% | +$366K |
|
|
TRT
2605
Trio-Tech International
TRT
$101M
| $1.06M | ﹤0.01% |
529,360
-5,000
| -0.9% | -$9.13K |
|
|
LEVL
2606
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $1.06M | ﹤0.01% |
41,985
+1,324
| +3% | +$32.5K |
|
|
VWTR
2607
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $1.05M | ﹤0.01% |
94,900
+2,000
| +2% | +$21.3K |
|
2608
IRIDEX
IRIX
$14.3M
| $1.05M | ﹤0.01% |
472,653
+33,101
| +8% | +$69.9K |
|
|
APTX
2609
DELISTED
Aptinyx Inc. Common Stock
APTX
| $1.05M | ﹤0.01% |
307,650
+219,450
| +249% | +$756K |
|
2610
Rhythm Pharmaceuticals
RYTM
$6.81B
| $1.05M | ﹤0.01% |
45,647
+34,947
| +327% | +$776K |
|
2611
TAT Technologies
TATT
$505M
| $1.05M | ﹤0.01% |
207,300
+4,100
| +2% | +$20.7K |
|
|
AUTO
2612
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $1.05M | ﹤0.01% |
423,390
+6,000
| +1% | +$15.6K |
|
|
ORBC
2613
DELISTED
ORBCOMM, Inc.
ORBC
| $1.04M | ﹤0.01% |
+248,120
| New | +$1.06M |
|
2614
Kforce
KFRC
$1.02B
| $1.04M | ﹤0.01% |
26,149
-12,800
| -33% | -$506K |
|
|
MYND
2615
Mynd.ai
MYND
$18M
| $1.03M | ﹤0.01% |
18,974
+2,610
| +16% | +$156K |
|
2616
Lisata Therapeutics
LSTA
$9.02M
| $1.03M | ﹤0.01% |
27,427
+1,304
| +5% | +$46.9K |
|
|
MITT
2617
TPG Mortgage Investment Trust
MITT
$222M
| $1.03M | ﹤0.01% |
+22,307
| New | +$1.03M |
|
2618
Mid Penn Bancorp
MPB
$971M
| $1.03M | ﹤0.01% |
35,774
-732
| -2% | -$19.4K |
|
|
LOV
2619
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $1.03M | ﹤0.01% |
227,364
+166,470
| +273% | +$857K |
|
2620
BayCom
BCML
$329M
| $1.03M | ﹤0.01% |
+45,100
| New | +$997K |
|
|
BSCM
2621
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $1.02M | ﹤0.01% |
47,605
+22,305
| +88% | +$479K |
|
2622
MIND Technology
MIND
$45.3M
| $1.02M | ﹤0.01% |
35,615
+280
| +0.8% | +$6.98K |
|
2623
Berkshire Hathaway Class A
BRK.A
$1.1T
| $1.02M | ﹤0.01% |
3
-88
| -97% | -$28.7M |
|
|
CTHR
2624
DELISTED
Charles & Colvard Ltd
CTHR
| $1.01M | ﹤0.01% |
71,461
-1,343
| -2% | -$18.9K |
|
|
NEOS
2625
DELISTED
Neos Therapeutics, Inc
NEOS
| $1.01M | ﹤0.01% |
666,868
+258,706
| +63% | +$388K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.